Skip to content
Welcome, thoughtbot's Giant Robots listeners!Start here
UK Startups and Innovation
22OCT

Gigaton lands $26m for plant autonomy

3 min read
16:30UTC

Gigaton, the first joint UCL and Cambridge spinout, closed a $26m Series A on 3 June with both university VC arms holding equity and three of the world's largest cement producers already paying for the software.

TechnologyDeveloping
Key takeaway

University funds now buy equity in their spinouts, and that IP is reaching global industrial customers within five years.

Gigaton, formerly Carbon Re, raised a $26m (£19.3m) Series A on Wednesday 3 June. Berlin early-stage fund Plural led the round. A Series A is a company's first major institutional round, and Gigaton closed it already billing Adani Cement, Heidelberg Materials and Holcim, three of the world's largest cement producers.⁠1

The company is the first joint spinout from University College London (UCL) and the University of Cambridge, built on licensed university research. Its software runs autonomous control of cement, steel, glass and chemical plants, the heaviest-emitting industrial processes. Gigaton puts the saving at $1m to $3m per plant each year and up to 30,000 tonnes of carbon dioxide, so one retrofitted works covers the software cost several times over.

Cambridge Enterprise Ventures and the UCL Technology Fund both bought equity in the round rather than taking a royalty as licensors. That changes the universities' position. A royalty pays a fixed slice regardless of outcome; an equity stake gives the institution upside if the company scales and aligns it with the founders. The BBB-anchored Lansdowne Partners spinout fund runs the same thesis at fund scale, institutional money buying into the university pipeline rather than waiting for it to graduate.

UK climate hard-tech has been finding capital lower down the stack, as with Bristol mycelium-panel maker Mykor in May. Gigaton sits a tier above that, with paying industrial customers across three continents five years after founding.

Deep Analysis

In plain English

Cement production is one of the dirtiest industrial processes on earth, responsible for roughly 8% of global CO2 emissions. Most of that comes from burning fuel to heat kilns to extremely high temperatures. Gigaton's software connects to a plant's existing sensors and uses machine learning to find the most fuel-efficient way to run the kiln at any given moment, adjusting in real time. The result is lower fuel consumption, lower CO2, and lower operating costs, typically saving the plant owner $1-3m a year. What makes Gigaton unusual is that it spun out simultaneously from two universities, UCL and Cambridge, which both hold equity stakes rather than charging the company royalties on their research. That arrangement is still rare enough to be noteworthy.

Deep Analysis
Root Causes

Three structural shifts converged to make Gigaton's model viable now.

Heavy industry decarbonisation targets, particularly under the EU's Carbon Border Adjustment Mechanism, create a financial penalty for cement and steel producers who do not reduce process emissions by 2026-30. That regulatory pressure converts Gigaton's $1-3m annual saving per plant from a nice-to-have into a compliance-cost offset, which changes procurement timelines.

AI models trained on process-sensor data from real industrial environments require years of operational data to outperform human operators. Gigaton's paying relationships with Adani Cement, Heidelberg Materials, and Holcim give it a sensor-data moat that a later entrant cannot replicate quickly.

University VC arms shifted from royalty licensing to equity co-investment during the 2020-2023 period following the 2019 Augar Review's criticism of short-term IP extraction. Cambridge Enterprise Ventures and UCL Technology Fund have both explicitly adopted equity-first models, which allowed the Gigaton structure to form.

What could happen next?
  • Precedent

    The joint UCL-Cambridge equity co-investor structure, if commercially successful, will be cited in future multi-university spinout negotiations across the Russell Group.

    Medium term · Assessed
  • Opportunity

    EU Carbon Border Adjustment Mechanism creates a time-limited acquisition window: heavy-industry customers face compliance deadlines that make Gigaton's ROI case easier to close in 2026-2028 than in 2030.

    Short term · Assessed
  • Risk

    Customer concentration in three cement producers means any of those three reducing capital expenditure or switching to a competitor product would materially affect Series B narrative.

    Short term · Assessed
First Reported In

Update #7 · OQC's £260m sets European quantum record

Cambridge Enterprise· 7 Jun 2026
Read original →
Different Perspectives
Abu Dhabi Investment Council
Abu Dhabi Investment Council
The Abu Dhabi Investment Council holds notes in Nscale's $3.36bn pre-IPO raise, beside Third Point, Apollo, Citadel and Nvidia. No British institution appears among the named holders of notes that convert into shares at Nscale's New York listing.
CDP Venture Capital
CDP Venture Capital
CDP Venture Capital, the venture arm of Italy's state lender, led TrueLayer's £20.4m round to expand Pay by Bank across Europe. A foreign state investor set the terms on a London fintech round in the same month the British Business Bank mostly followed.
EDBI
EDBI
Singapore's state investor EDBI joined Universal Quantum's Series A of more than $100m, and the Sussex company is opening its first research centre outside Europe in Singapore. British state money is absent from the largest Series A by a UK quantum company.
Forbion
Forbion
Forbion co-led OMass Therapeutics' $310m Series C with Bain Capital Life Sciences and Novo Holdings, while the British Business Bank and Syncona followed. The terms of the Oxford spinout's round were set by investors from three countries, none of them Britain.
British Business Bank
British Business Bank
The Bank committed £180m to six AI funds on 15 October with no UK-deployment condition, yet led the first close of Microbiotica's £36m Series C. That lead, with Airtel Money choosing London for its £5.3bn debut, is the evidence that British money and markets still set some terms.
Stryker Corporation
Stryker Corporation
Stryker called its roughly $400m CMR Surgical deal its entry into soft-tissue robotics, taking US sales rights for Versius, a board seat and an exclusive option over 100% of the company. The option lets Stryker choose whether and when a Cambridge robot maker becomes part of an American group.

Written with AI from Lowdown's published reporting. Not individually reviewed by an editor. Editorial standards.